| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |